已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis

医学 内科学 DLCO公司 荟萃分析 子群分析 科克伦图书馆 安慰剂 不利影响 特发性肺纤维化 肺功能测试 随机对照试验 中医药 肺功能 肺 扩散能力 病理 替代医学
作者
Kun Ji,MA Jian-ling,WANG Liangmin,Niuniu Li,Shangjuan Dong,Shi Li-qing
出处
期刊:Evidence-based Complementary and Alternative Medicine [Hindawi Publishing Corporation]
卷期号:2020: 1-11 被引量:15
标识
DOI:10.1155/2020/1752387
摘要

To evaluate the efficacy and safety of traditional Chinese medicine (TCM) on lung function and quality of life of idiopathic pulmonary fibrosis (IPF) patients by meta-analysis.Randomized controlled trials (RCTs) related to TCM and IPF were searched on PubMed, EMBASE Cochrane Library, ClinicalTrials, China National Knowledge Infrastructure (CNKI), Wanfang Database, Chin VIP Information (VIP), and Chinese Biomedical Database (CBM) until December 2018. Standard mean difference (SMD) and 95% CI were calculated for the measurements related to lung function (FEV1/FVC, FVC%, FEV1%, TLC%, DLCO% or DLCO, and VC%) and other parameters (PO2, 6MWD, and SGRQ) when comparing TCM treatment to the control group. Relative risk (RR) and 95% CI of adverse events (AEs) were calculated to assess the safety of TCM.A total of 40 RCTs comparing TCM to western medicine (WM) and involving 3194 IPF patients were eligible for the meta-analysis. The pooled results showed that TCM treatment improved significantly PO2 (SMD = 0.80, 95% CI 0.54 to 1.06, p < 0.001), FEV1% (SMD = 0.57, 95% CI 0.42 to 0.71, p < 0.001), DLCO% (SMD = 0.38, 95% CI 0.28 to 0.48, p < 0.001), 6MWD (SMD = 0.70, 95% CI 0.56 to 0.84, p < 0.001) and other measurements and reduced SGRQ scores (SMD = −0.51, 95% CI −0.70 to −0.22, p < 0.001). Subgroup analysis of different study durations (3 months, ≥ 6 months) and comparison models (TCM vs. WM, TCM + WM vs. WM or TCM vs. placebo) showed similar results. No significant difference of risk of AEs was observed between both groups (RR = 0.66, 95% CI: 0.27–1.60, p=0.352). There was no obvious publication bias, and the pooled results were stable according to sensitivity analysis.To the best of our knowledge, the present study had the largest sample size. Our results indicated that TCM treatment may help provide benefit to the lung function, exercise capacity, and quality of life of IPF patients, alone or combined with WM, when compared to WM. More rigorous RCTs were needed in the future.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
聪明海云完成签到,获得积分20
刚刚
机灵猕猴桃完成签到,获得积分10
刚刚
科研通AI6.4的应助被Qiqi采纳,获得10
刚刚
MoeBella发布了新的文献求助10
刚刚
1秒前
阿南发布了新的文献求助10
2秒前
flora发布了新的文献求助10
3秒前
yoonkk完成签到,获得积分10
4秒前
李爱国的应助被林夏采纳,获得10
4秒前
4秒前
传奇3的应助被academician采纳,获得10
6秒前
共享精神的应助被chengqian采纳,获得10
6秒前
8秒前
Yl完成签到 ,获得积分10
8秒前
小蘑菇的应助被xc采纳,获得10
9秒前
SpaceThing发布了新的文献求助10
10秒前
无名小羊完成签到 ,获得积分10
12秒前
12秒前
12秒前
12秒前
ASIMISMO完成签到,获得积分10
12秒前
葛煜完成签到 ,获得积分10
14秒前
852的应助被原神大王采纳,获得10
15秒前
15秒前
16秒前
彩色的迎梦完成签到,获得积分10
16秒前
SaSS发布了新的文献求助10
17秒前
ljz完成签到 ,获得积分20
17秒前
xiaoxu发布了新的文献求助10
18秒前
18秒前
阿南发布了新的文献求助10
19秒前
在水一方的应助被Lzc采纳,获得10
21秒前
林夏发布了新的文献求助10
21秒前
科研通AI6.4的应助被xc采纳,获得10
21秒前
酷波er的应助被Jeremy采纳,获得10
22秒前
雨齐完成签到,获得积分10
23秒前
烟花的应助被SaSS采纳,获得10
25秒前
冲冲冲发布了新的文献求助10
25秒前
遥章完成签到,获得积分10
26秒前
郝磊完成签到 ,获得积分10
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189694
求助须知:如何正确求助?哪些是违规求助? 9576952
关于积分的说明 21850481
捐赠科研通 7787646
什么是DOI,文献DOI怎么找? 3435759
关于科研通互助平台的介绍 2559813
邀请新用户注册赠送积分活动 2482624